Hendon Partners

Valuation

4 articles on valuation from Hendon Partners' home care M&A advisory team.

Valuation

ABA Therapy and Autism Services M&A Multiples in 2026

Applied Behavior Analysis (ABA) and autism services have been one of the most active behavioral health M&A segments of the past decade. Here is how ABA agencies are valued in 2026, how multiples are evolving after the post-2022 reset, and what buyers actually look for.

May 4, 2026

Valuation

Medicare Advantage Penetration and Its Impact on Home Health Valuation in 2026

Medicare Advantage now accounts for more than half of all Medicare beneficiaries — and the rate differential between MA and traditional Medicare is one of the most consequential variables in home health agency valuation in 2026. Here is how buyers are modeling MA exposure.

May 4, 2026

Valuation

Pediatric Home Health Agency Valuation in 2026: A Complete Guide

Pediatric home health and pediatric private duty nursing agencies are commanding premium multiples in 2026 — often 6× to 9× EBITDA — driven by acute clinical complexity, scarcity of qualified nurses, and intense PE platform interest. Here is how buyers actually value pediatric agencies.

April 26, 2026

Valuation

The CMS 80/20 Rule: What It Means for Medicaid Home Care Agency Valuations

The CMS Medicaid Access Rule — commonly known as the 80/20 rule — requires that 80% of Medicaid HCBS personal care, home health, and homemaker payments go directly to caregiver compensation. For Medicaid-dependent home care agencies, the rule is one of the most consequential valuation variables of the next decade.

April 25, 2026